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doi:10.1016/j.ejvs.2008.06.029Abstract Objectives: Comparison of Reverse Foam Sclerotherapy of the great saphenous vein
(GSV) combed with sapheno-femoral junction (SFJ) ligation to standard (Babcock) stripping
and invagination (Pin) stripping in a prospective clinical series.
Design: Prospective clinical series.
Materials and methods: 90 consecutive limbs of 82 patients with incompetence of the GSV
resulting in varicose veins were prospectively randomised into 3 groups of 30, treated by SFJ
ligation and either reverse foam sclerotherapy, standard stripping or invagination stripping
of the GSV. Outcomes were assessed post-operatively and at 2-weeks follow-up. Peri-operative
blood loss (24 hrs), analgesic requirement, bruising and residual varicosities were assessed.
Bruising was assessed by both patients and independent assessors using questionnaires.
Results: SFJ ligation plus reverse foam sclerotherapy of the GSV was associated with signifi-
cantly less blood loss, bruising and post-op discomfort than either of the stripping techniques.
(p< 0.001, Mann-Whitney)
Conclusion: Standard stripping of the GSV and invagination stripping are not associated with
major discomfort and problems in the early post-operative period. SFJ ligation and GSV reverse
foam sclerotherapy yielded greater patient satisfaction with less post-op bruising and discom-
fort and reduced analgesic requirements.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.a, Broomfield Hospital, Chelmsford, Essex CM1 7ET, United Kingdom. Tel.: þ44 776 425 9385.
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Just over 100 years ago Keller1 described a novel method of
removing the saphenous vein by using an inverting stripping
method to remove the vein in segments combined with divi-
sion of its tributaries. Mayo2 introduced ring stripping in
1906. Ten years later, Homans3 introduced the concept of
flush ligation of the GSV at the sapheno-femoral junction
along with all its tributaries. Intraluminal strippers were
introduced by Babcock4 in 1907 and flexible strippers by
Myers5 in 1954. GSV conservation by sapheno-femoral liga-
tion without saphenous stripping was reintroduced in the
mid 1980s and 90s in a drive to preserve the saphenous
vein for arterial bypass grafts6e8 and also because avoiding
stripping decreased postoperative pain and allowed earlier
functional recovery9 after a procedure that could be done
under local anaesthesia.10 The concept of sequential avul-
sion of the GSV under local anaesthesia was a further
attempt to minimise the consequences of saphenous
stripping.11
The most widely used treatment in the UK for managing
varices arising from incompetence of the great saphenous
vein (GSV) is sapheno-femoral junction (SFJ) ligation
combined with GSV stripping.12 A number of new methods
of endovenous treatment have been introduced in recent
years to facilitate early ambulation and minimise post-
operative discomfort. These include foam sclerotherapy,
radiofrequency and laser ablation. Liquid sclerotherapy is
the oldest of these treatments, first introduced around
160 years ago but when used in the traditional way is of
limited efficacy in treating varices associated with incom-
petence of the saphenous trunk. Foam sclerosants was first
described by Orbach in 194413 but in the era before duplex
ultrasonography the advantage of these was not fully
appreciated. Cabrera14 introduced the use of ultrasound
guided sclerotherapy using micro-foam in 1997 as an alter-
native to surgical treatment. A new technique of creating
foam with small bubbles was described by Tessari in
200015 who used 2 syringes and a three-way tap to produce
sclerosant foam.
Conventional surgical treatment of varicose veins
involves ligation of incompetent communications between
deep and superficial veins. Ligation of the SFJ without
stripping the GSV is not sufficient in the long term to control
varices and is associated with a high rate of recurrence.16e18
Reflux continues in the saphenous trunk following this
operation due to inflow from tributaries and leads to the
formation of further varicose veins. Even following appar-
ently adequate ligation, incompetent communications
between the SFJ and superficial varices arise due to recanal-
isation19 and neovascularisation.20,21 Stripping the saphe-
nous trunk improves the outcome in patients where this
vein is incompetent. Stripping of the GSV can be achieved
by standard stripping using a Babcock-type flexible stripper
or else by an invagination technique. This method is based
on Keller’s method and was introduced in 1963 by Van Der
Stricht who used a strong thread to invaginate the vein.
Oesch, in 1993,22 used a metal pin stripper to facilitate
inverting stripping which is reputed to be less traumatic
than standard stripping. Recurrence after GSV stripping
commonly arises from incompetence of the anterioraccessory saphenous vein and which can be present in up
to 10% of cases, a missed true duplex GSV present in 1% of
cases23 or from inadequate dissection and division of
tributaries of the SFJ.
The three main drawbacks of stripping the GSV in the
thigh are blood loss, bruising and post-operative pain. We
have introduced the option of completing the flush ligation
and division of the GSV at the SFJ with a novel technique of
reverse delivery of foam sclerosant directly into the
incompetent GSV to obliterate this vein rather than
stripping it. The aim of our study was to measure post-
operative bleeding, pain, analgesic use and thigh bruising
as outcome measures to compare our method of foam
sclerotherapy ablation to standard stripping and pin-
stripping.
Materials and Methods
Patients
Patients undergoing treatment for varicose veins in the
vascular clinics at Broomfield Hospital were considered for
inclusion in this clinical series. We aimed to study 90
consecutive patients with CEAP clinical classes 2 and 3
symptomatic primary varicose veins with SFJ and GSV
reflux, who agreed to accept the treatment modality
chosen for them on a random basis. This would yield 3
groups of 30 procedures each. The three procedures in the
study consisted of flush SFJ ligation with division of
tributaries followed by either a) standard stripping of the
GSV using a flexible intraluminal stripper fitted with an
olive to strip the vein from groin to knee, b) GSV
invagination stripping using the pin stripper according to
the technique described by Oesch in 199322 or c) reverse
foam obliteration of the GSV described below.
Ninety identical closed envelopes were prepared
containing allocation instructions for 30 standard GSV
stripping, 30 invagination stripping and 30 reverse foam
sclerotherapy procedures. The envelopes were shuffled and
patients would pick an envelope after consenting to
participation. The protocol for this study was considered
and approved by the local committee for medical ethics.
82 consecutive patients (32 men 50 women) presenting
to our vascular clinic with symptomatic varicose veins
(CEAP clinical classes 2 & 3) were included in our study.
Diagnostic duplex ultrasound assessment was performed
allowing us to select patients with primary SFJ and GSV
incompetence as the cause of their varices. Diagnostic
venous duplex scans were performed by accredited
vascular technicians using the Toshiba Aplio XV using the
12 MHz linear phased array matrix transducer. Reflux
duration of 0.5 seconds after a manual calf compres-
sion-release manoeuvre was used to define pathological
reflux at the SFJ.24 We included 74 patients with unilateral
saphenous incompetence and bilateral incompetence in
a further 8 patients. The median age for these patients
was 44 years (range 18e67 years). Median height to weight
ratio was 2.29 cm/kg (range 1.79e3.04 cm/kg).
All patients gave informed written consent to treatment
according to random assignment into any of the three
groups after being fully informed about the three
A Prospective Clinical Series 487techniques. In keeping with our standard practice all
patients had one leg operated at a time giving a total of
90 procedures.
Patients were admitted on the morning of surgery and
operated under general anaesthesia on a morning list. For
the sake of the study, patients were discharged 1 day
post-operatively to allow uniform management of dress-
ings and assessment and removal of drains. Observation
for complications including the occurrence of rashes,
allergic reactions, cough, malaise and headache in
patients receiving foam sclerotherapy was recorded by
recovery nurses prior to transfer from the theatre
recovery area and by ward nurses while routine post-op
observations were being recorded. The standard stripping
group was made up of 13 men and 17 women with a mean
age of 46yrs (18e66 yrs). The invagination stripping group
was made up of 15 men and 15 women with a mean age of
47 yrs (25e67 yrs). The Reverse foam sclerotherapy group
was made up of 8 men and 22 women with a mean age of
45 yrs (22e66 yrs).Reverse foam sclerotherapy
The patient’s leg and groin were prepped with aqueous
povidone iodine and draped with the entire leg exposed
from above the groin to just above the ankle. After groin
dissection, division of tributaries and flush ligation of the
SFJ, the GSV was divided and canulated distally using a 5 Fr
angiography catheter at a point approximately 10 cm distal
to the knee. Ultrasound imaging (Sonosite 180, Sonosite
Inc, Bothell, WA, USA) was used to position the catheter
and subsequently to guide tumescent infiltration of local
anaesthetic (40 mls 0.5% Bupivacaine with adrenaline
diluted in 500 ml of 0.9% Saline solution) along the length
of the GSV/catheter. This achieved the dual effect of com-
pressing the vein and decreasing its capacity as well as post
operative analgesia.
The foam was then prepared mixing 3 ml of 1% STS
(Sodium Tetradecyl Sulphate/ Fibrovein) and 3 ml of air
using Tessari’s technique; two 10 ml syringes and a three-
way tap. The resulting 6 ml of foam was injected into the
collapsed vein via the angiography catheter as this was
withdrawn along the length of the vein (hence the term
reverse foam).The proximal GSV was tied 5 cm distal to
its cut end and the redundant few cm of vein were excised.
Complete filling of the vein with foam was checked by
ultrasonography.
To ensure uniformity between the procedures, tumes-
cent anaesthesia was also applied along the length of the
GSV prior to stripping in both the Standard stripping
technique and the Invagination technique. Associated
varicosities were removed by multiple phlebectomies
through small incisions with local anaesthetic infiltration
in all cases prior to the tumescent anaesthetic along the
GSV.
In all techniques a size 10 Fr suction drain was placed in
the groin wound with the distal end of the drain inserted
along the proximal GSV track. All legs were dressed post-
operatively with foam strip padding applied externally over
the length of the GSV track which was secured using an
elastic adhesive bandage (Panelast). At one day post-opdrains were removed and drained volumes were recorded;
leg dressings were taken down and replaced by Class II
graduated compression stockings which were worn continu-
ously until follow-up at 15 days. All patients were
prescribed 75 mg diclofenac bd as post-op analgesia and
were asked to keep a diary of consumption of this and other
analgesia used post-op.
Follow-up
Thigh bruising, residual varicosities, post-op discomfort and
analgesic use were assessed at the 15-day post-op clinic
visit. Patients completed questionnaires dealing with anal-
gesic use, post-operative discomfort and thigh bruising
(absent, moderate, severe) prior to being seen by medical
staff. A surgeon and a vascular nurse specialist measured
the extent of thigh bruising (cm2) and recorded the
patients’ satisfaction with the results and residual varicos-
ities. Bruising was assessed in the thigh along the stripping
or ablation line and not in the calf where any bruising would
be related to the avulsions. Bruising involving <15 cm2 was
described as moderate and >15 cm2 as severe. Patients
who had undergone foam sclerosis of the GSV underwent
duplex ultrasonography to ensure complete obliteration of
the GSV and were also assessed for the presence of skin
pigmentation and thrombophlebitis. The patients in the
other 2 groups were not scanned at this point.
Results were analysed using SPSS11. Data were
assumed to be of non-normal distribution so the descriptors
used are the median and inter-quartile range and signifi-
cance testing for differences between groups was assessed
by a Mann-Whitney u test.
Results
Technical results
There were 9 technical failures. In 2 patients undergoing
standard stripping and 1 patient undergoing invagination
stripping it was impossible to pass the stripper to below
the knee. In 3 patients undergoing invagination stripping
the GSV tore before an adequate length was stripped. In
3 patients undergoing reverse foam it was not possible to
pass the catheter to the desired level. Duplex scanning of
the GSV in patients who had been treated by foam
sclerotherapy group at the 15-day post-op assessment
showed that 26 out of the 27 GSVs were completely
obliterated and the remaining 1 had a patent segment
related to incompetent perforators above the knee.
Blood loss at 18e24 hrs
Median values for blood loss were 25 ml (Interquartile
range, IQR, 25e35 ml) for standard stripping, 25 mls (IQR
20e35 ml) for the invagination group and 15 mls (IQR 10e
20 mls) for the reverse foam group. (Fig. 1). The difference
between the first 2 groups was non statistically significant
but there was significantly less blood loss for the reverse
foam group compared to the other two techniques
(p< 0.001, Mann Whitney).
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Figure 2 Use of analgesia. Consumption has been classified
as none, occasional and regular.
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Figure 1 Blood loss at 18e24 hours. Box and whisker plot
shows the median, inter-quartile range with maximum and
minimum values.
488 R. Abela et al.Analgesic use post-op
77% of patients in the reverse foam group used no analgesia
and the remaining 23% used it occasionally. Only 23% of
invagination patients needed no analgesia; 63% needed it
occasionally and 13% regularly. In the standard stripping
group, 17% used no analgesia and 83% used it occasionally
(Fig. 2). Again significantly fewer patients in the reverse
foam sclerotherapy group required analgesia and these
only needed it occasionally (p< 0.001, Mann Whitney).
Thigh bruising
There was significantly less thigh bruising reported by
patients (pZ 0.005) and also observers (p< 0.001) in the
reverse foam group. The difference in thigh bruising
between the standard stripping and invagination tech-
niques was not significant as reported by both the patients
(pZ 0.187) and observers (pZ 0.575). Questionnaires
showed that only 13% of patients who underwent standard
GSV stripping and GSV invagination assessed themselves
as having no bruising. In the reverse foam sclerotherapy
group 67% thought that they had no bruising (Table 1).
The observations the patients and the assessors are shown
in Fig. 3.
Adverse effects of foam sclerotherapy
No clinically detectable adverse effects attributable to the
use of foam sclerotherapy were reported post-operatively
or during the follow-up period.Table 1 Two week post-op bruising reported by patients and o
Bruising Stripping Invagin
Patients% Observers% Patient
None 13 20 13
Moderate 50 73 70
significant 37 7 17Discussion
Since the late nineties, minimal access techniques have
become well established in the management of varicose
veins in the United States, Europe and Australia. The
primary appeal of radiofrequency, laser and chemical
ablation is the significant reduction in post procedural
morbidity and pain compared to conventional surgery. An
added benefit is that most varicose veins can be treated
using these techniques with local anaesthetic within a clinic
setting. This results in a low-cost treatment with minimal
post-operative consequences.
The use of foam sclerotherapy in the UK seems to have
lagged behind that in Europe, the US and Australia. NICE
guidelines were issued in June 2006 while the German
Society of Phlebology had published guidelines in 200425,26
issued from the 2nd European Consensus Meeting on Foam
Sclerotherapy, April 2003. The recurring exhortation in
these and other reviews and guidelines is that the conver-
sion of Polidocanol or Sodium Tetradecyl Sulphate into
foam by any method represents ‘off-label’ use of the scle-
rosants. Commercial preparations such as Varisolve
(British Technology Group PLC, London, UK) and lauroma-
crogol 400 microfoam have not yet gained approval neces-
sitating the continued use of home made foam.
Early comparisons of the results of sclerotherapy and
surgery have shown better long-term results for surgery27,28
however this has been changing since the replacement of
liquid sclerotherapy with foam.29 Foam sclerotherapy has
clear advantages over liquid in the treatment of larger vari-
ces and saphenous trunk incompetence,30,31 and is maxi-
mally effective when ultrasound-guided treatment is
given. One draw-back is the need for close follow-up andbservers
ation Reverse Foam
s% Observers% Patients% Observers%
13 67 77
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7 3 0
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Figure 3 Percentage of a) patients and b) observers reporting no, moderate or significant bruising at two weeks post-op.
A Prospective Clinical Series 489the need for repeated injection for treatment of recur-
rence.32 It is hoped that this combination of modalities in
a single treatment session will offer long term results which
will avoid the need for further intervention.
Combination of treatment modalities has been common
practice in the treatment of varicose veins. This most
frequently took the form of liquid sclerotherapy of residual
varicosities after definitive surgical treatment of varicose
veins. Combinations have also been used in stepped proto-
cols and also as primary interventions. The combination of
liquid sclerotherapy with high saphenous vein ligation33 in an
attempt to minimize the recurrence rate has not been
uniformly successful.29,34 The combination of foam sclero-
therapy and high ligation was addressed in a recent study35
where patients were transferred to the ultrasound suite
immediately post-operatively for ultrasound-guided foam
injection of the GSV through an access point at below-knee
level. This study has eliminated the need for transfer since
ultrasound imaging can easily be used in operating theatre
whilst maintaining sterility of the operative site. The use
of high ligation and division of the SFJ and division of
tributaries was used to try to minimize future recurrence
of varicosities by recruitment of these tributaries.
The procedure of reverse foam sclerotherapy introduced
in this paper addresses a number of loop-holes in the
treatment of varicose veins. Though for the purposes of this
study and to allow comparison with the stripping proce-
dures, the procedure was performed under general anaes-
thetic, it would be equally feasible under local anaesthetic
subject to patient preference.
Complementing flush ligation at the SFJ with foam
sclerotherapy to decrease post-operative recurrence rates,
is expected achieve a superior effect to the previously
reported use of liquid sclerosant. Also when compared to
closed procedures, since the GSV has been dissociated from
the deep femoral vein, the head of foam in the proximal
vein is not subject to back pressure from the column ofblood in the femoral vein at the SFJ and the risk of spillage
of foam into the deep system at this point is removed
though seepage through perforators remains a concern.
Open cannulation of the GSV under direct vision with
ultrasound confirmation allows accurate delivery of foam
along the full length of the vein allowing evident proximal
displacement of blood from the lumen as the catheter is
withdrawn. Completion of filling of the vein is evident as
foam will leak from the proximal open end of the vein
though this was further confirmed using ultrasound prior to
dressing the leg. Resection of a proximal 5 cm length of vein
after injection also ensures completion and distances the
cut ends to decrease the likelihood of neovascularisation.
Ultrasound can also be used during this procedure to locate
perforators and allow the application of pressure at their
communication points to decrease passage of foam into
the deep veins.
This paper addresses blood-loss, post-operative pain/
use of analgesics and extent of thigh bruising as a measure
of immediate procedural success as well as patient satis-
faction, cosmesis and quality of life. Long-term follow-up
of this series will be forthcoming to allow us to confirm
whether long-term results confirm expectations.References
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